Company Search:
Advanced Search
Sponsored Links
Anthera Pharmaceuticals, Incorporation Company Snapshot
Anthera Pharmaceuticals, Incorporation operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Anthera Pharmaceuticals, Incorporation with three other companies in this sector in the United States: TG Therapeutics Inc (2016 sales of $152,381.00 of which 100% was License Revenue), Mabvax Therapeutics Holdings Inc ($148,054.00 ), and Jaguar Health Inc ($141,523.00 ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Anthera Pharmaceuticals, Incorporation
  Stock Performance Chart for Anthera Pharmaceuticals, Incorporation
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 1.35
(Figures in U.S. Dollars)
1 Week -17.9%   13 Weeks -12.9%  
4 Weeks -17.7%   52 Weeks -74.9%  
Anthera Pharmaceuticals, Incorporation Key Data:
  Ticker: ANTH Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 145,000
(Year Ending Jan 2017).
Employees: 33
  Currency: U.S. Dollars Market Cap: 18,697,065
  Fiscal Yr Ends: December Shares Outstanding: 13,849,678
  Share Type: Common Closely Held Shares: 1,039,200
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.